Topchoice Medical Co., Inc. (SHA:600763)
China
· Delayed Price · Currency is CNY 43.26
-0.23 (-0.53%)
Apr 29, 2026, 3:00 PM CST
Topchoice Medical Co. Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 19,350 | 17,985 | 19,860 | 24,513 | 49,055 | 63,807 | Upgrade
|
| Market Cap Growth | -4.44% | -9.44% | -18.98% | -50.03% | -23.12% | -28.03% | Upgrade
|
| Enterprise Value | 20,067 | 19,085 | 21,039 | 25,551 | 49,953 | 63,811 | Upgrade
|
| Last Close Price | 43.26 | 40.21 | 43.92 | 53.55 | 107.17 | 139.40 | Upgrade
|
| PE Ratio | 38.55 | 35.83 | 39.61 | 48.98 | 89.47 | 90.79 | Upgrade
|
| Forward PE | 35.97 | 37.43 | 46.14 | 29.21 | 76.15 | 75.61 | Upgrade
|
| PS Ratio | 6.62 | 6.17 | 6.91 | 8.61 | 18.04 | 22.95 | Upgrade
|
| PB Ratio | 4.04 | 3.94 | 4.56 | 5.93 | 13.56 | 20.29 | Upgrade
|
| P/TBV Ratio | 4.63 | 4.51 | 5.13 | 6.61 | 15.10 | 22.65 | Upgrade
|
| P/FCF Ratio | 32.91 | 31.86 | 46.05 | 73.81 | 197.39 | 111.53 | Upgrade
|
| P/OCF Ratio | 23.48 | 22.19 | 26.01 | 29.15 | 73.21 | 67.92 | Upgrade
|
| PEG Ratio | 4.79 | 2.34 | 2.34 | 2.34 | 2.34 | 2.34 | Upgrade
|
| EV/Sales Ratio | 6.86 | 6.55 | 7.32 | 8.98 | 18.37 | 22.95 | Upgrade
|
| EV/EBITDA Ratio | 22.70 | 23.85 | 27.00 | 32.78 | 61.17 | 63.76 | Upgrade
|
| EV/EBIT Ratio | 28.90 | 26.74 | 30.43 | 36.80 | 67.97 | 68.66 | Upgrade
|
| EV/FCF Ratio | 34.13 | 33.81 | 48.78 | 76.93 | 201.01 | 111.54 | Upgrade
|
| Debt / Equity Ratio | 0.24 | 0.24 | 0.33 | 0.35 | 0.32 | 0.41 | Upgrade
|
| Debt / EBITDA Ratio | 1.43 | 1.39 | 1.62 | 1.65 | 1.27 | 1.20 | Upgrade
|
| Debt / FCF Ratio | 1.95 | 1.97 | 3.35 | 4.39 | 4.64 | 2.27 | Upgrade
|
| Net Debt / Equity Ratio | 0.07 | 0.09 | 0.19 | 0.21 | 0.14 | 0.14 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.44 | 0.52 | 1.06 | 1.11 | 0.64 | 0.46 | Upgrade
|
| Net Debt / FCF Ratio | 0.60 | 0.73 | 1.91 | 2.60 | 2.11 | 0.80 | Upgrade
|
| Asset Turnover | 0.47 | 0.48 | 0.47 | 0.51 | 0.54 | 0.69 | Upgrade
|
| Inventory Turnover | 66.96 | 71.86 | 64.51 | 73.37 | 74.42 | 78.94 | Upgrade
|
| Quick Ratio | 1.58 | 1.38 | 1.55 | 1.15 | 1.67 | 1.56 | Upgrade
|
| Current Ratio | 1.71 | 1.49 | 1.68 | 1.40 | 2.33 | 1.63 | Upgrade
|
| Return on Equity (ROE) | 12.67% | 13.18% | 13.48% | 14.92% | 18.21% | 28.62% | Upgrade
|
| Return on Assets (ROA) | 7.12% | 7.30% | 7.06% | 7.74% | 9.09% | 14.49% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.79% | 11.72% | 11.20% | 12.40% | 15.84% | 27.26% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.80% | 13.30% | 12.30% | 12.90% | 15.70% | 21.50% | Upgrade
|
| Earnings Yield | 2.61% | 2.79% | 2.53% | 2.04% | 1.12% | 1.10% | Upgrade
|
| FCF Yield | 3.04% | 3.14% | 2.17% | 1.35% | 0.51% | 0.90% | Upgrade
|
| Dividend Yield | 1.03% | - | 1.03% | 0.58% | - | - | Upgrade
|
| Payout Ratio | 41.41% | 41.62% | 29.89% | 2.25% | 1.22% | 1.83% | Upgrade
|
| Buyback Yield / Dilution | -0.36% | -0.15% | -0.15% | 0.50% | 0.09% | -0.32% | Upgrade
|
| Total Shareholder Return | 0.70% | -0.15% | 0.88% | 1.08% | 0.09% | -0.32% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.